Spirometry and peak expiratory flow in the primary care management of COPD

Primary Care Respiratory Journal

Volumn 13, Issue 1, 2004, Pages 5-8

  White, Patrick ^a,b   Chavannes, Niels ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Crown Dale Medical Centre   (United Kingdom)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; COPD; Primary care; Spirometry

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC VALUE; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MEASUREMENT; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; REPRODUCIBILITY; RESPIRATORY CARE; REVIEW; SPIROMETRY; VITAL CAPACITY;

EID: 1342283124     PISSN: 14714418     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcrj.2003.11.009     Document Type: Review

References (24)

1. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997;52(Suppl 5):S1-28.
2. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001;46(8):798-825.
3. Schermer TRJ, Folgering HTM, Buttema BJAM, Jacobs JE, van Schayck CP, van Weel C. The value of spirometry for primary care: asthma and COPD. Prim Care Respir J 2000;9(3):51-5.
4. General Practitioners Committee, The NHS Confederation. New GMS Contract 2003. Investing in general practice. London: British Medical Association; 2003.
5. van Schayck CP, Chavannes NH. Detection of asthma and chronic obstructive pulmonary disease in primary care. Eur Respir J Suppl 2003;39:16s-22s.
6. van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ. Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study. Br Med J 2002;324(7350):1370.
7. Kelly CA, Gibson GJ. Relation between FEV and peak expiratory flow in patients with chronic airflow obstruction. Thorax 1988;43:335-6.
8. Miller MR, Dickinson SA, Hitchings DJ. The accuracy of portable peak flow meters. Thorax 1992;47:904-9.
9. Miller MR, Ouanjer PH. Peak flow meters: a problem of scale. Br Med J 1994;308(6928):548-9.
10. Pedersen OF, Miller MR, van der Mark TW. Performance testing new peak flow meters. Eur Respir J 1998;12:261-2.
11. Quanjer PH, Lebowitz MD, Gregg I, Miller MR, Pedersen OF. Peak expiratory flow: conclusions and recommendations of a Working Party of the European Respiratory Society. Eur Respir J 1997;24(Suppl):2S-8S.
12. 1). Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care. Eur Respir J 2002;20(Suppl 38):397s.
13. Bush A, Cramer D. Guidelines for the measurement of respiratory-function. Respir Med 1994;88(10):798.
14. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung-volumes and forced ventilatory flows-Report Working Party Standardization of Lung-Function Tests European-Community for Steel and Coal-Official Statement of the European Respiratory Society. Eur Respir J 1993;6:5-40.
15. Nunn AJ, Gregg I. New regression equations for predicting peak expiratory flow in adults. Br Med J 1989;298:1068-70.
16. Roca J, Burgos F, Sunyer J, Saez M, Chinn S, Anto JM, et al. References values for forced spirometry. Eur Respir J 1998;11(6):1354-62.
17. Miller MR, Quanjer PH. Peak flow meters-a problem of scale. Br Med J 1994;308(6928):548-9.
18. Pedersen OF, Miller MR. The Peak Flow Working Group: test of portable peak flow meters by explosive decompression. Eur Respir J 1997;24(Suppl):23S-5S.
19. Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories, American Thoracic Society. Standardization of Spirometry, Am. J. Respir. Crit. Care Med. 1995;152:1107-36.
20. Ram FS, Sestini P. Regular inhaled short acting beta2 agonists for the management of stable chronic obstructive pulmonary disease: cochrane systematic review and meta-analysis. Thorax 2003;58(7):580-4.
21. Irwin RS, Madison JM. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2003;348(26):2679-81.
22. Donohue JF, van Noord JA, Bateman ED, Langley SJ, Lee A, Witek Jr TJ, et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002;122(1):47-55.
23. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160(2):542-9.
24. Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RM, Rea HH. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 1999;116(2):416-23.